These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 27521890)
1. Insulin-like growth factor-binding protein-3 inhibits IGF-1-induced proliferation of human hepatocellular carcinoma cells by controlling bFGF and PDGF autocrine/paracrine loops. Ma Y; Han CC; Li Y; Wang Y; Wei W Biochem Biophys Res Commun; 2016 Sep; 478(2):964-9. PubMed ID: 27521890 [TBL] [Abstract][Full Text] [Related]
2. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. Huynh H; Chow PK; Ooi LL; Soo KC Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812 [TBL] [Abstract][Full Text] [Related]
3. PDGF, bFGF and IGF-I stimulate the proliferation of intervertebral disc cells in vitro via the activation of the ERK and Akt signaling pathways. Pratsinis H; Kletsas D Eur Spine J; 2007 Nov; 16(11):1858-66. PubMed ID: 17763874 [TBL] [Abstract][Full Text] [Related]
4. High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma. Aishima S; Basaki Y; Oda Y; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Hosoi F; Maruyama Y; Fotovati A; Oie S; Ono M; Ueno T; Sata M; Yano H; Kojiro M; Kuwano M; Tsuneyoshi M Cancer Sci; 2006 Nov; 97(11):1182-90. PubMed ID: 16965600 [TBL] [Abstract][Full Text] [Related]
5. The insulin-like growth factor-1 and expression of its binding protein‑3 in chronic hepatitis C and hepatocellular carcinoma. Adamek A; Kasprzak A; Mikoś H; Przybyszewska W; Seraszek-Jaros A; Czajka A; Sterzyńska K; Mozer-Lisewska I Oncol Rep; 2013 Sep; 30(3):1337-45. PubMed ID: 23784592 [TBL] [Abstract][Full Text] [Related]
6. Regulation of insulin-like growth factor (IGF)-binding protein expression by growth factors and cytokines alters IGF-mediated proliferation of postnatal lung fibroblasts. Price WA Exp Lung Res; 2004 Jun; 30(4):261-83. PubMed ID: 15204833 [TBL] [Abstract][Full Text] [Related]
7. Serum from Chronic Hepatitis B Patients Promotes Growth and Proliferation via the IGF-II/IGF-IR/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma Cells. Ji Y; Wang Z; Chen H; Zhang L; Zhuo F; Yang Q Cell Physiol Biochem; 2018; 47(1):39-53. PubMed ID: 29763915 [TBL] [Abstract][Full Text] [Related]
11. PDGF-AA and bFGF mediate B104CM-induced proliferation of oligodendrocyte precursor cells. Hu JG; Wu XJ; Feng YF; Xi GM; Wang ZH; Zhou JS; Lü HZ Int J Mol Med; 2012 Nov; 30(5):1113-8. PubMed ID: 22922759 [TBL] [Abstract][Full Text] [Related]
12. Effects of growth factors on insulin-like growth factor binding protein (IGFBP) secretion by primary porcine satellite cell cultures. Yi Z; Hathaway MR; Dayton WR; White ME J Anim Sci; 2001 Nov; 79(11):2820-6. PubMed ID: 11768110 [TBL] [Abstract][Full Text] [Related]
13. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression. Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061 [TBL] [Abstract][Full Text] [Related]
14. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells. Shimizu M; Shirakami Y; Sakai H; Tatebe H; Nakagawa T; Hara Y; Weinstein IB; Moriwaki H Cancer Lett; 2008 Apr; 262(1):10-8. PubMed ID: 18164805 [TBL] [Abstract][Full Text] [Related]
15. Daintain/AIF-1 accelerates the activation of insulin-like growth factor-1 receptor signaling pathway in HepG2 cells. Jia S; Du Z; Jiang H; Huang X; Chen Z; Chen N Oncol Rep; 2015 Jul; 34(1):511-7. PubMed ID: 25998745 [TBL] [Abstract][Full Text] [Related]
16. Synergistic induction of in vivo angiogenesis by the combination of insulin-like growth factor-II and epidermal growth factor. Lee YM; Bae MH; Lee OH; Moon EJ; Moon CK; Kim WH; Kim KW Oncol Rep; 2004 Oct; 12(4):843-8. PubMed ID: 15375510 [TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor regulates IGF-I binding proteins in the clonal osteoblastic cell line MC3T3-E1. Hurley MM; Abreu C; Hakeda Y J Bone Miner Res; 1995 Feb; 10(2):222-30. PubMed ID: 7538725 [TBL] [Abstract][Full Text] [Related]
18. A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma. Assal RA; El Tayebi HM; Hosny KA; Esmat G; Abdelaziz AI Mol Med Rep; 2015 Jul; 12(1):645-50. PubMed ID: 25739014 [TBL] [Abstract][Full Text] [Related]
19. Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer. Hochscheid R; Jaques G; Wegmann B J Endocrinol; 2000 Sep; 166(3):553-63. PubMed ID: 10974650 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody. Yue L; Wang Y; Wang H; Gao H; Liang J; Sui A; Xiang J; Zhou F; Xu C; Zhao W; Liang W; Yao R Oncol Rep; 2012 Oct; 28(4):1453-60. PubMed ID: 22895605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]